Literature DB >> 20184499

An interim prosthesis program for lower limb amputees: comparison of public and private models of service.

Robert Gordon1, Christopher Magee, Anna Frazer, Craig Evans, Kathryn McCosker.   

Abstract

This study compared the outcomes of an interim mechanical prosthesis program for lower limb amputees operated under a public and private model of service. Over a two-year period, 60 transtibial amputees were fitted with an interim prosthesis as part of their early amputee care. Thirty-four patients received early amputee care under a public model of service, whereby a prosthetist was employed to provide the interim mechanical prosthesis service. The remaining 26 patients received early amputee care under a private model of service, where an external company was contracted to provide the interim mechanical prosthesis service. The results suggested comparable clinical outcomes between the two patient groups. However, the public model appeared to be less expensive with the average labour cost per patient being 29.0% lower compared with the private model. The results suggest that a public model of service may provide a more comprehensive and less expensive interim prosthesis program for lower limb amputees.

Entities:  

Mesh:

Year:  2010        PMID: 20184499     DOI: 10.3109/03093640903510980

Source DB:  PubMed          Journal:  Prosthet Orthot Int        ISSN: 0309-3646            Impact factor:   1.895


  2 in total

1.  ECONOMIC EVALUATIONS OF INTERVENTIONS FOR TRANSTIBIAL AMPUTEES: A SCOPING REVIEW OF COMPARATIVE STUDIES.

Authors:  M Jason Highsmith; Jason T Kahle; Amanda Lewandowski; Tyler D Klenow; John J Orriola; Rebecca M Miro; Owen T Hill; Sylvia Ursula Raschke; Michael S Orendurff; James T Highsmith; Bryce S Sutton
Journal:  Technol Innov       Date:  2016-09-01

Review 2.  What Is the Magnitude and Long-term Economic Cost of Care of the British Military Afghanistan Amputee Cohort?

Authors:  D S Edwards; Rhodri D Phillip; Nick Bosanquet; Anthony M J Bull; Jon C Clasper
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.